A 4048 (see companion bill S 2535) – New Jersey
Introduced: 2022 Status: In Process
The bill provides that if a contract does not have in its network a provider who can provide any part, attachment, or accessory necessary to the continued function of a preexisting cochlear implant, the contract …
A 4294 (see companion bill S 2824) – New Jersey
Introduced: 2022 Status: In Process
The bill removes a provision of law that requires health insurance carriers to offer individual health plans, through the Individual Health Coverage Program, as a condition of participation in the small employer health insurance market. …
A 4305 (see companion bill S 220) – New Jersey
Introduced: 2018 Status: Inactive / Dead
SETS LEVEL FOR HEALTH CARE BENEFITS; REQUIRES EMPLOYEE CONTRIBUTIONS; PROHIBITS REIMBURSEMENT OF MEDICARE PART B; ADDS MEMBER TO SHBP/SEHBP PLAN DESIGN COMMITTEES; REQUIRES RETIREES TO PURCHASE HEALTH BENEFITS THROUGH EXCHANGES; PROVIDES SUBSIDES FOR OUT-OF-POCKET COSTS. …
A 440 – New Jersey
Introduced: 2018 Status: Inactive / Dead
ESTABLISHES CENTER FOR THE STUDY OF HEALTH CARE BILLING DATA. The Center’s purpose is to analyze the health care provider billing data that is to be provided to the Center by carriers offering health benefits …
A 450 – New Jersey
Introduced: 2018 Status: Inactive / Dead
LIMITS PAYMENTS UNDER HEALTH BENEFITS PLANS TO IN-NETWORK AMOUNTS IN CERTAIN CIRCUMSTANCES; PROHIBITS OUT-OF-NETWORK HEALTH PROVIDERS FROM CHARGING CARRIERS MORE THAN 150 PERCENT OF MEDICARE RATE IN CERTAIN CIRCUMSTANCES. With respect to a covered service …
A 4761 (see companion bill S 3201) – New Jersey
Introduced: 2018 Status: Inactive / Dead
REVISES CERTAIN ASPECTS OF OUT-OF-NETWORK ARBITRATION PROCESS UNDER THE “OUT-OF-NETWORK CONSUMER PROTECTION, TRANSPARENCY, COST CONTAINMENT AND ACCOUNTABILITY ACT.” The act establishes an arbitration system for out-of-network health care services provided in certain emergency and inadvertent …
A 5046 – New York
Introduced: 2021 Status: In Process
Relates to access to appropriate drugs at reasonable prices, formulary exceptions, standing prior authorizations and external appeals; to access to retail pharmacies, prescription synchronization, limits on patient drug costs, explanations of benefits and rebates; to …
A 5137 (see companion bill S 3480) – New Jersey
Introduced: 2023 Status: In Process
The Small Business Health Insurance Affordability Act; revises certain requirements for individual and small employer health benefits plans.
A 5200 – New Jersey
Introduced: 2023 Status: In Process
Requires health insurance coverage of prescribed anti-obesity medication.
A 5411 (see companion bill S 4620) – New York
Introduced: 2021 Status: In Process
Requires health plans operating in the state to furnish the cost, benefit, and coverage data as required to the enrollee, his or her health care provider, or the third-party of his or her choosing.
A 547 – New Jersey
Introduced: 2020 Status: Inactive / Dead
“Health Care Consumer’s Out-of-Network Protection, Transparency, Cost Containment and Accountability Act.” This bill is intended to provide remedies for individuals who are treated by physicians and treated in facilities that do not belong to a …
A 553 (see companion bill S 301) – New Jersey
Introduced: 2022 Status: In Process
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
A 562 (see companion bill 4838) – New York
Introduced: 2021 Status: In Process
Shortens time frames during which an insurer has to determine whether a pre-authorization request is medically necessary from three business days to three days.
A 5743 (see companion bill S 4062) – New Jersey
Introduced: 2019 Status: Inactive / Dead
Requires carriers to pass prescription drug savings to consumers.
A 5786 (see companion bill S 4350) – New Jersey
Introduced: 2019 Status: Inactive / Dead
Places $100 cap on amount paid by covered persons for purchase of insulin drugs; requires Division of Consumer Affairs to investigate insulin prices.
A 5948 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.